CA2448997A1 - Dosage et conditionnement de medicaments a liberation controlee - Google Patents

Dosage et conditionnement de medicaments a liberation controlee Download PDF

Info

Publication number
CA2448997A1
CA2448997A1 CA002448997A CA2448997A CA2448997A1 CA 2448997 A1 CA2448997 A1 CA 2448997A1 CA 002448997 A CA002448997 A CA 002448997A CA 2448997 A CA2448997 A CA 2448997A CA 2448997 A1 CA2448997 A1 CA 2448997A1
Authority
CA
Canada
Prior art keywords
combination
delivery package
pharmaceutical delivery
plus
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002448997A
Other languages
English (en)
Inventor
Andrew L. Abrams
Anand V. Gumaste
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microdose Therapeutx Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002614902A priority Critical patent/CA2614902A1/fr
Priority to CA002614899A priority patent/CA2614899A1/fr
Publication of CA2448997A1 publication Critical patent/CA2448997A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)

Abstract

L'invention concerne le conditionnement de quantités contrôlées de médicaments en poudre, sous conditionnement pour libération contrôlée, ces quantités étant déterminées par mesure électrostatique. L'invention concerne également des formes de conditionnement se prêtant à une thérapie par délivrance combinée de médicaments, lesdits conditionnements comprenant au moins deux principes pharmaceutiques actifs séparés l'un de l'autre mais conditionnés ensemble.
CA002448997A 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee Abandoned CA2448997A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002614902A CA2614902A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee
CA002614899A CA2614899A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29478601P 2001-05-31 2001-05-31
US60/294,786 2001-05-31
PCT/US2002/016185 WO2002096347A2 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CA002614902A Division CA2614902A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee
CA002614899A Division CA2614899A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee

Publications (1)

Publication Number Publication Date
CA2448997A1 true CA2448997A1 (fr) 2002-12-05

Family

ID=23134944

Family Applications (3)

Application Number Title Priority Date Filing Date
CA002448997A Abandoned CA2448997A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee
CA002614902A Abandoned CA2614902A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee
CA002614899A Abandoned CA2614899A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA002614902A Abandoned CA2614902A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee
CA002614899A Abandoned CA2614899A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee

Country Status (8)

Country Link
EP (1) EP1408907A4 (fr)
JP (1) JP2005514966A (fr)
AU (1) AU2002303840A1 (fr)
BR (1) BRPI0209720A2 (fr)
CA (3) CA2448997A1 (fr)
NZ (1) NZ529696A (fr)
WO (1) WO2002096347A2 (fr)
ZA (1) ZA200402466B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4331572A3 (fr) * 2019-10-04 2024-06-05 Xeolas Pharmaceuticals Ltd. Formulation de suspension pédiatrique

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428809B1 (en) 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
MY142179A (en) * 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
US20100260669A1 (en) * 2004-05-13 2010-10-14 Anthony Joonkyoo Yun Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
EP1889198B1 (fr) 2005-04-28 2014-11-26 Proteus Digital Health, Inc. Systeme pharma-informatique
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
CA2625776A1 (fr) * 2005-10-14 2007-04-26 Microdose Technologies, Inc. Conditionnement pharmaceutique d'une combinaison posologique orale
EP2063771A1 (fr) 2007-03-09 2009-06-03 Proteus Biomedical, Inc. Dispositif organique à antenne déployable
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
EA201190281A1 (ru) 2009-04-28 2012-04-30 Протиус Байомедикал, Инк. Высоконадежные проглатываемые отметчики режима и способы их применения
CN105381524A (zh) 2010-01-05 2016-03-09 微剂量治疗技术公司 吸入设备和方法
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
EP2642983A4 (fr) * 2010-11-22 2014-03-12 Proteus Digital Health Inc Dispositif ingérable avec produit pharmaceutique
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2015112603A1 (fr) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Produit ingérable pouvant être mâché et système de communication associé
EP2874886B1 (fr) 2012-07-23 2023-12-20 Otsuka Pharmaceutical Co., Ltd. Techniques de fabrication de marqueurs d'événements ingérables comprenant un constituant ingérable
MX340182B (es) 2012-10-18 2016-06-28 Proteus Digital Health Inc Aparato, sistema, y metodo para optimizar adaptativamente la disipacion de energia y la energia de difusion en una fuente de energia para un dispositivo de comunicacion.
TWI659994B (zh) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 高度可膨脹之聚合型薄膜及包含彼之組成物
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
MX2019000888A (es) 2016-07-22 2019-06-03 Proteus Digital Health Inc Percepcion y deteccion electromagnetica de marcadores de evento ingeribles.
IL265827B2 (en) 2016-10-26 2023-03-01 Proteus Digital Health Inc Methods for producing capsules with ingestible event markers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
US5714007A (en) 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
US5699649A (en) 1996-07-02 1997-12-23 Abrams; Andrew L. Metering and packaging device for dry powders
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
US5960609A (en) * 1998-06-12 1999-10-05 Microdose Technologies, Inc. Metering and packaging method and device for pharmaceuticals and drugs
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4331572A3 (fr) * 2019-10-04 2024-06-05 Xeolas Pharmaceuticals Ltd. Formulation de suspension pédiatrique

Also Published As

Publication number Publication date
CA2614899A1 (fr) 2002-12-05
WO2002096347A2 (fr) 2002-12-05
EP1408907A2 (fr) 2004-04-21
AU2002303840A1 (en) 2002-12-09
ZA200402466B (en) 2006-07-26
WO2002096347A3 (fr) 2003-03-27
NZ529696A (en) 2008-07-31
JP2005514966A (ja) 2005-05-26
EP1408907A4 (fr) 2010-02-24
BRPI0209720A2 (pt) 2017-06-13
CA2614902A1 (fr) 2002-12-05

Similar Documents

Publication Publication Date Title
CA2448997A1 (fr) Dosage et conditionnement de medicaments a liberation controlee
US20020142035A1 (en) Metering and packaging of controlled release medication
US20040156903A1 (en) Metering and packaging of controlled release medication
CA2668884C (fr) Formulations pharmaceutiques en couches
EP1482914B1 (fr) Dispositif de distribution de medicament implantable pour l'oeil
JP2011501736A (ja) 経口投与用配合剤型医薬パッケージング
US7622137B2 (en) Dosage forms contained within a capsule or sachet
EP1933815A2 (fr) Conditionnement pharmaceutique d'une combinaison posologique orale
EP2061448B1 (fr) Formulation à libération prolongée de naltréxone
CZ420997A3 (cs) Vrstevnatá tableta pro řízené uvolňování účinných látek
EP2029116A1 (fr) Formes pharmaceutiques sécables
AU770828B2 (en) Metering and packaging of controlled release medication
AU2004200545B9 (en) Metering and packaging of controlled release medication
CA3087300A1 (fr) Methode de production d'un systeme d'administration de medicament
Patel et al. Current status of technologies and devices for chronotherapeutic drug delivery systems
Dharmamoorthy et al. Chronotherapeutics: A range of newer drug delivery approaches for better patient compliance
KR20200111705A (ko) 약물 전달 시스템
Mathew et al. Recent Technologies in Pulsatile Drug Delivery: A Review

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued